Biophysical Assays DNA Small Molecule 
Sygnature Discovery
JUNE 17, 2024
We are adept at designing biophysical assays for complex targets, utilising a comprehensive range of options to create the most fitting biophysical assay for each specific target system. Sygnature Discovery’s Biophysical Assay Development Capabilities: 1.
Drug Discovery World
AUGUST 9, 2024
The SAMDI technology is amenable to any buffer component, encouraging the optimisation of the assay based on the biological needs of the target. “Affinity selection MS (ASMS) to identify small molecule binders to protein, oligonucleotide, and cellular targets, is promising,” Gurard-Levin adds.
Expert insights. Personalized for you.
52 
Let's personalize your content